Somatostatin: Physiology and Clinical Applications (Q39721576)

14 September 2017

1 reference

title

Somatostatin. Physiology and clinical applications (English)

1 reference

14 September 2017

Somatostatin: Physiology and Clinical Applications (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

3 April 2023

0 references

J. E. Gerich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347198

3 April 2023

G. S. Patton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347198

3 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=347198

3 April 2023

publication date

1 March 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0025712516318132?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

https://api.elsevier.com/content/article/PII:S0025712516318132?httpAccept=text/plain

3 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Medical Clinics of North America

3 April 2023

published in

1 reference

14 September 2017

62

1 reference

14 September 2017

2

1 reference

14 September 2017

375-392

1 reference

Inhibition of insulin secretion by somatostatin

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Glucagon control of fasting glucose in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Interaction of Somatostatin, Glucagon, and Insulin on Hepatic Glucose Output in the Normal Dog

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Radioimmunoassay for GH-Release Inhibiting Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Increase in basal and thyrotropin-releasing hormone (TRH)-stimulated secretion of thyrotropin (TSH) by passive immunization with antiserum to somatostatin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Blockade of the Stress-Induced Decrease in Blood GH by Anti-Somatostatin Serum in Rats1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The Influence of Hypophysectomy on the Stores of Somatostatin in the Hypothalamus and Pituitary Stem

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Cyclic AMP-dependent stimulation of somatostatin secretion by isolated rat islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Growth hormone release inhibiting hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Impairment of platelet function by growth-hormone release-inhibiting hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Reversal of somatostatin inhibition of insulin and glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The hypoglycaemic action of somatostatin in the anaesthetized dog

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin suppresses secretin and pancreatic exocrine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Separate autoantibodies to human pancreatic glucagon and somatostatin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of growth hormone secretion in the rat by synthetic somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Central nervous system effects of hypothalamic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The Regional Distribution of Somatostatin in the Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The Effect of Somatostatin on Glucose Uptake and Production by Rat Tissues in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The effect of somatostatin on platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The effect of somatostatin on plasma noradrenaline and plasma adrenaline concentrations during exercise and hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Reversal of somatostatin inhibition of insulin secretion by calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin does not suppress plasma parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition by somatostatin of glucose induced 3′: 5′-monophosphate (Cyclic AMP) accumulation and insulin release in isolated pancreatic islets of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin: A potent inhibitor of ACTH-Hypersecretion in adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin Inhibition of Glucose-, Tolbutamide-, Theophylline-, Cytochalasin B-, and Calcium-Stimulated Insulin Release in Monolayer Cultures of Rat Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Metabolic effects of long-term somatostatin infusion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: Studies with somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin: physiological and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Some Actions of Growth Hormone Release Inhibiting Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of Gastrin Release by Somatostatin in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The roles of insulin and glucagon in the regulation of gluconeogenesis in the postabsorptive dog

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Stimulation of guanosine 3',5'-cyclic monophosphate accumulation in rat anterior pituitary gland in vitro by synthetic somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effects of somatostatin on hemostasis in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effect of GH-releasing factor and GH-inhibiting factor on the release and concentration of GH in pituitaries incubated in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Pancreatic somatostatinoma. Clinical features and physiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Comparison of Cyclic and Linear Forms of Somatostatin in the Inhibition of Growth Hormone, Insulin and Glucagon Secretion1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The Effect of Somatostatin on TSH Levels in Patients with Primary Hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inactivation of somatostatin (GH‐RIH) and its analogs by crude and partially purified rat brain extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibitory effect of somatostatin (SRIF) on the release of growth hormone (GH) induced in the rat by electrical stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Hypothalamic peptides: New evidence for "peptidergic" pathways in the C.N.S

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Extended Somatostatin Treatment of a Patient with Bleeding Ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Antidiabetic action of somatostatin--assessed by the artificial pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The effect of somatostatin on coagulation and platelet function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of calcium uptake by somatostatin in isolated rat islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The microanatomy of the islets of langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Evidence for the D-cell of the pancreas secreting somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Functional subdivision of islets of Langerhans and possible role of D cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Decreased pancreatic somatostatin (SRIF) concentration in spontaneously diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Increased somatostatin content of islets from streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon [proceedings]

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Response of pancreatic immunoreactive somatostatin to arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibitory effect of somatostatin on dibutyryl cyclic AMP-induced insulin and growth hormone release in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Disappearance of plasma growth hormone in acromegaly and protein-calorie malnutrition after somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Coagulation studies and platelet function after somatostatin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Depressant action of TRH, LH-RH and somatostatin on activity of central neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

An intrarenal effect of somatostatin on water excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Central site of action of somatostatin (SRIF): role of hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

D-Trp8-somatostatin: An analog of somatostatin more potent than the native molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Regulation of in Vitro Insulin Release from a Transplantable Syrian Hamster Insulinoma1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition of growth hormone release in humans by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Interaction of somatostatin and calcium in regulating insulin release from isolated pancreatic islets of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Antiserum to Somatostatin Prevents Stress-Induced Inhibition of Growth Hormone Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Suppression and Stimulation Mechanisms Controlling Glucagon Secretion in a Case of Islet-Cell Tumor Producing Glucagon, Insulin, and Gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin inhibition of insulin release from freshly isolated and organ cultured rat islets of langerhans in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition by somatostatin of ACTH secretion in Nelson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Possible Roles of the Pancreatic D-cell in the Normal and Diabetic States

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Anatomic and phylogenetic distribution of somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effects of somatostatin on the secretion of thyrotropin and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

The Inhibitory Effect of Somatostatin on Growth Hormone, Insulin and Glucagon Secretion in Diabetes Mellitus1

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931813-2

7 January 2021

Fiber connections in the hypothalamus and some autonomic functions

9

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Somatostatin analogs with selected biologic activities

3 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Studies on the inhibitory effect of somatostatin on glucose induced insulin release in the isolated perfused rat pancreas

3 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Somatostatin: diabetes and acromegaly

3 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Somatostatin and the Endocrine Pancreas

3 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Diabetes without glucagon

3 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

Role of glucagon in human diabetic ketoacidosis: studies using somatostatin

3 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

3 April 2023

Somatostatin, 1976

112

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31813-2

3 April 2023

Identifiers

0 references

1 reference